Office of New Drugs Custom Medical Queries(OCMQs) for Safety Signal Detection in Clinical Trial Data
Office of New Drugs (OND), U.S. Food and Drug Administration · June 24, 2026
FDA Office of New Drugs webinar explaining the purpose, design, and use of Office of New Drugs Custom Medical Queries (OCMQs), announcing OCMQ version 4.0 and the MAP 6025.8 guidance and describing maintenance, algorithmic queries, and public resources.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.